comprehensive -WSS

comprehensive

author：focus 2025-09-29 03:47:07 - browse：9354

Boston Scientific headquarters -- Health coverage from STAT — Boston Scientific is growing its urology portfolio with the Axonics acquisition. Steven Senne/AP

Boston Scientific said it will buy Axonics, a device company treating urinary and bowel disorders, on Monday. The deal is worth $3.7 billion.

It’s the first billion-dollar medical device deal of 2024 — a rare occurrence in 2023, which saw just a handful of medtech acquisitions reaching the billion threshold. Boston Scientific said it expects to close the deal in the first half of this year. Axonics’ stock increased by 20% in light of the news; Boston Scientific’s dropped slightly.

Boston Scientific has acquired companies across all medtech sectors in the past year. The device maker bought Apollo Endosurgery, a company selling surgical tools to combat obesity, for $615 million in 2023. In September of 2023, Boston Scientific bought pain relief company Relievant for $850 million.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： FDA's naming rule on biosimilars has undermined competition

knowledge

WSS

Eliminate the waiting period for sterilization covered by Medicaid

Why the world’s most expensive drug might be worth the price

Covid vaccines: Private market messier than government rollout

Readout Newsletter: Blackstone Life Sciences, Merck, Bluebird Bio

STAT Virtual Event: How to Increase Diversity in Clinical Trials

Intercept Pharmaceuticals sells itself for less than $1 billion

focus

comprehensive

Wikipedia

New air purifier tech could be key to improving indoor air quality

Readout Newsletter: Merck, Vertex, and Viking updates

Wildfire smoke exposes gaps in outdoor worker protections

Merck drug for rare lung condition set for approval in U.S.

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Oprah kicked off a national conversation on obesity. Let's have it

Heart attack and stroke risk calculators need revising

FDA advisers vote against ALS treatment from BrainStorm

What does generative AI mean for health care? We asked experts

Covid vaccines: Private market messier than government rollout

entertainment

STAT Virtual Event: How to Increase Diversity in Clinical Trials

Adam's Biotech Scorecard: A closer look at Viking Therapeutics, PDS Biotech

Covid vaccines: Private market messier than government rollout

Food as medicine: Medically tailored meals may get standardized

Covid vaccine financial winners and losers, from Pfizer to Novavax

Cigna to pay $172 million to settle Medicare Advantage fraud probe

hotspot

knowledge

entertainment

Wikipedia